Skip to content

Primary Biliary Cholangitis 3 C2751695

Published: July 22, 2026Updated: August 20, 2026

A chronic autoimmune condition that damages the liver's bile ducts over time. It mainly occurs in women and may progress without treatment. Regular monitoring and medication can help control symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hepatobiliary)

Generalized symptoms

(hepatobiliary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Pruritus

(hepatobiliary)

Xanthelasma

(hepatobiliary)

Jaundice with weight loss

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Ursodeoxycholic Acid Monotherapy

Primary pharmacological intervention using UDCA to enhance bile secretion and reduce liver inflammation. This remains the cornerstone of treatment for this PBC variant with documented efficacy in slowing fibrosis progression.

medication

Additional treatment options

Fibrate Combination Therapy

Addition of bezafibrate or fenofibrate to UDCA in incomplete responders. These peroxisome proliferator-activated receptor agonists may improve biochemical response in selected patients.

medication

Milk Thistle (Silymarin) Support

Herbal supplement sometimes used as complementary support for liver function. While evidence is limited, some patients report subjective improvement in fatigue and well-being.

complementary

Enhanced Fibrosis Monitoring

Serial non-invasive fibrosis assessment using elastography (FibroScan) to track disease progression. This allows for early identification of cirrhotic changes requiring intensified management.

monitoring

Chronic Disease Counseling

Psychological support addressing the chronic nature of PBC and associated fatigue. Cognitive behavioral approaches can help patients develop coping strategies for managing uncertainty and treatment adherence.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Primary Biliary Cholangitis 3 C2751695?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hirschfield GM, Gershwin ME. American Association for the Study of Liver Diseases Practice Guidelines for Primary Biliary Cholangitis. Hepatology. 2021.

guideline2021
2

Lleo A, Wang GQ, Gershwin ME, Invernizzi P. Primary biliary cholangitis: a comprehensive review. J Hepatol. 2020.

review2020
3

Nevens F, Andreone P, Mazzella G. A randomized controlled trial of obeticholic acid monotherapy in patients with primary biliary cholangitis. Gastroenterology. 2019.

clinical_trial2019
4

Zhang L, Liu J, Wang J. Efficacy and safety of fibrates for primary biliary cholangitis: a systematic review and meta-analysis. Hepatology. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Primary Biliary Cholangitis 3 C2751695. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy